Impact of a Multidisciplinary Service Line and Program for Transcatheter Device Closure of the Neonatal Ductus Arteriosus.
Neonate
Patent ductus arteriosus
Prematurity
Quality improvement
Transcatheter therapy
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
28 Aug 2024
28 Aug 2024
Historique:
received:
18
05
2024
accepted:
13
08
2024
medline:
28
8
2024
pubmed:
28
8
2024
entrez:
28
8
2024
Statut:
aheadofprint
Résumé
Outline a quality initiative establishing an institutional service line for neonatal transcatheter device closure of the patent ductus arteriosus (TDC-PDA). A retrospective descriptive observational study surrounds programmatic approach to TDC-PDA in premature neonates with process measure spanning education, implementation, referral, and post-procedural care. Metrics tracked pre- and post-program creation with statistical analyses performed. Neonatal TDC-PDA referrals increased exponentially since program inception (n = 13 in year prior; n = 42 year 1; n = 74 year 2), especially in patients weighing less than 1.3 kg (12.5%; 55%; 50%), and were associated with an increased procedural success rate (81%; 95%; 99%). Procedural checklist creation decreased procedural "out of isolette" time (median 93 min; 59; 52), and procedural-related complication or clinical sequelae (19%; 12%; 4%). A multidisciplinary service line and program dedicated to neonatal TDC-PDA can result in a significant increase in referrals as well as procedural efficacy and safety for this medically fragile population.
Identifiants
pubmed: 39196349
doi: 10.1007/s00246-024-03629-z
pii: 10.1007/s00246-024-03629-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Sathanandam SK, Gutfinger D, O’Brien L, Forbes TJ, Gillespie MJ, Berman DP et al (2020) Amplatzer piccolo occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients >/=700 grams. Catheter Cardiovasc Interv 96(6):1266–1276
doi: 10.1002/ccd.28973
pubmed: 32433821
pmcid: 7754477
Morray BH, Sathanandam SK, Forbes T, Gillespie M, Berman D, Armstrong AK et al (2023) 3-year follow-up of a prospective, multicenter study of the amplatzer piccolo occluder for transcatheter patent ductus arteriosus closure in children >/= 700 grams. J Perinatol 43(10):1238–1244
doi: 10.1038/s41372-023-01741-1
pubmed: 37587183
pmcid: 10541325
Kuntz MT, Staffa SJ, Graham D, Faraoni D, Levy P, DiNardo J et al (2022) Trend and outcomes for surgical versus transcatheter patent ductus arteriosus closure in neonates and infants at US Children’s Hospitals. J Am Heart Assoc 11(1):e022776
doi: 10.1161/JAHA.121.022776
pubmed: 34970919
Bischoff AR, Kennedy KF, Backes CH, Sathanandam S, McNamara PJ (2023) Percutaneous closure of the patent ductus arteriosus in infants </=2 kg: IMPACT registry insights. Pediatrics. https://doi.org/10.1542/peds.2023-061460
doi: 10.1542/peds.2023-061460
pubmed: 37529882
Bischoff AR, Jasani B, Sathanandam SK, Backes C, Weisz DE, McNamara PJ (2021) Percutaneous closure of patent ductus arteriosus in infants 1.5 kg or less: a meta-analysis. J Pediatr 230:84-92 e14
doi: 10.1016/j.jpeds.2020.10.035
pubmed: 33098843
Barry OM, Gudausky TM, Balzer DT, Bocks ML, Boe BA, Callahan R et al (2023) Safety and short-term outcomes for infants < 25 kg undergoing PDA device closure: A C3PO registry study. Pediatr Cardiol 44(6):1406–1413
doi: 10.1007/s00246-023-03147-4
pubmed: 36995404
Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Hakansson S et al (2019) PDA-tolerate trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. J Pediatr 205:41–8 e6
doi: 10.1016/j.jpeds.2018.09.012
pubmed: 30340932
Hundscheid T, Onland W, Kooi EMW, Vijlbrief DC, de Vries WB, Dijkman KP et al (2023) Expectant management or early ibuprofen for patent ductus arteriosus. N Engl J Med 388(11):980–990
doi: 10.1056/NEJMoa2207418
pubmed: 36477458
Kaluarachchi DC, Rysavy MA, Carper BA, Chock VY, Laughon MM, Backes CH et al (2023) Secular trends in patent ductus arteriosus management in infants born preterm in the national institute of child health and human development neonatal research network. J Pediatr 266:113877
doi: 10.1016/j.jpeds.2023.113877
pubmed: 38135028
Hubbard R, Edmonds K, Rydalch E, Pawelek O, Griffin E, Gautam N (2020) Anesthetic management of catheter-based patent ductus arteriosus closure in neonates weighing <3 kg: a retrospective observational study. Paediatr Anaesth 30(4):506–510
doi: 10.1111/pan.13838
pubmed: 32040230
Sathanandam S, Gutfinger D, Morray B, Berman D, Gillespie M, Forbes T et al (2021) Consensus guidelines for the prevention and management of periprocedural complications of transcatheter patent ductus arteriosus closure with the amplatzer piccolo occluder in extremely low birth weight infants. Pediatr Cardiol 42(6):1258–1274
doi: 10.1007/s00246-021-02665-3
pubmed: 34195869
pmcid: 8292293
Alhalabi E, Zestos M, Kobayashi D, McKelvey GM, Taylor RA (2022) Interventions to prevent hypothermia in extremely preterm low-weight infants undergoing cardiac catheterisation. BMJ Open Qual. https://doi.org/10.1136/bmjoq-2021-001773
doi: 10.1136/bmjoq-2021-001773
pubmed: 36122994
pmcid: 9486285
Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D (2016) SQUIRE 2.0 (standards for quality improvement reporting excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf 25(12):986–992
doi: 10.1136/bmjqs-2015-004411
pubmed: 26369893
Bell SW, Kong JCH, Clark DA, Carne P, Skinner S, Pillinger S et al (2022) The national aeronautics and space administration-task load index: NASA-TLX: evaluation of its use in surgery. ANZ J Surg 92(11):3022–3028
doi: 10.1111/ans.17830
pubmed: 35674407
pmcid: 9796827
Kennedy-Metz LR, Wolfe HL, Dias RD, Yule SJ, Zenati MA (2020) Surgery task load index in cardiac surgery: measuring cognitive load among teams. Surg Innov 27(6):602–607
doi: 10.1177/1553350620934931
pubmed: 32938323
pmcid: 7744397
Apalodimas L, Waller Iii BR, Philip R, Crawford J, Cunningham J, Sathanandam S (2019) A comprehensive program for preterm infants with patent ductus arteriosus. Congenit Heart Dis 14(1):90–94
doi: 10.1111/chd.12705
pubmed: 30811791
McNamara PJ, Giesinger RE, Backes CH (2019) Cardiac catheterisation for closure of patent ductus arteriosus. Lancet Child Adolesc Health 3(5):290–292
doi: 10.1016/S2352-4642(19)30088-4
pubmed: 30928352
Sathanandam S, Agrawal H, Chilakala S, Johnson J, Allen K, Knott-Craig C et al (2019) Can transcatheter PDA closure be performed in neonates </=1000 grams? Memphis Exp Congenit Heart Dis 14(1):79–84
doi: 10.1111/chd.12700
Aw TC, Chan B, Singh Y (2023) Transport and anaesthesia consideration for transcatheter patent ductus arteriosus closure in premature infants. J Cardiovasc Dev Dis. 10(9):377
pubmed: 37754806
pmcid: 10531776
Willis A, Pereiras L, Head T, Dupuis G, Sessums J, Corder G et al (2019) Transport of extremely low birth weight neonates for persistent ductus arteriosus closure in the catheterization lab. Congenit Heart Dis 14(1):69–73
doi: 10.1111/chd.12706
pubmed: 30811788